DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $390 | +14.4% | 26,400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $341 | +31.7% | 26,400 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $259 | +13.1% | 26,400 | +22.8% | 0.00% | 0.0% |
| Q4 2022 | $229 | -99.9% | 21,500 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $224,000 | -17.3% | 21,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $271,000 | +16.3% | 21,500 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $233,000 | -23.1% | 21,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $303,000 | – | 21,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |